All Type of News
Green Cross to launch "Laennec" an injectable placenta.
Green Cross has launched Laennec injectable placenta preparation in the market under a certain distribution arrangement with GCJBP who is producing Laennec under a joint venture between Green Cross and Japanese Biolog...
CEO of MSD Korea elected as KRPIA chairman.The Korea Multinationala Drug Corporation group, KRPIA, elected Mr. Mark Timney, the CEO of MSD Korea as the 7th chairman of KRPIA on June 14 succeeding Mr. Michael Richter who...
|
Can backdoor wholesale margins be eliminated?
Seoul Pharmaceutical Wholesalers Association (SPWA) recently run the Distribution Normalization Commission and determined the firs project targeted on the removal of the backdoor distribution margins. However, it is w...
KFDA to mull over how to treat unacceptable bulk drugs
The KFDA seems to be in anguish how to treat an unacceptable bulk drug with reference to the DMF, a bulk drug master file report system, which is still being reviewed on ongoing receit of its submission from the bulk ...
Government and Industry in different views on drug economy assessment system.
The drug economy assessment system promoted by the government and the Health Insurance Review Agency (HIRA) revealed just an opposite position between the government and the drug industry.
The HIRA and the Korea S...
Sanofi set up clinical research and R&D unit in Korea.
For the first time in Korea following Singapore, a foreign multinational drug corporation, Sanofi-Aventis, has established "Clinical Research Unit" for the new drug R&D and the international clinical study management ...
Pfizer awarded 5 Korean scientists on overseas scientific papers.Pfizer Korea took an award ceremony on June 12 with the 3rd Pfizer Overseas Scientific Paper Award to 5 scientists during the 22th conference of the Korea Society of Male Scienc...
|
Gleevec inventor from Novartis visits Korea.
Dr. Alex Matter, the developer of Gleevec and the chief researcher of Novartis tropical medicine institute will visit to "Bio camp" of Korea and deliver a lecture titled "new drug development in the third millennium ...
HIRA to cut off drugs of high cost for the effect.
In the conference to discuss "Introduction of drug economic evaluation system" jointly sponsored by the Health Insurance Review Agency (HIRA) and the Korea Society of health economy and policy on June 14, the HIRA may...
Bayer Korea to resume wholesale business under contract renewal.
Most of pharmaceutical companies are in trouble with the stronghold wholesalers and the associated wholesalers but Bayer Korea decided to continue wholesale business under an amicable relationship with wholesalers.
...
